Cargando…

Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk

OBJECTIVE: To study the prognosis of people with newly diagnosed type 2 diabetes as per the American Diabetes Association (ADA) 2010 definition but without diabetes as per the ADA 2009 definition. RESEARCH DESIGN AND METHODS: A total of 2,002 participants of the Ludwigshafen Risk and Cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Silbernagel, Guenther, Kleber, Marcus E., Grammer, Tanja B., Winkelmann, Bernhard R., Boehm, Bernhard O., März, Winfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198301/
https://www.ncbi.nlm.nih.gov/pubmed/21911772
http://dx.doi.org/10.2337/dc11-1046
_version_ 1782214410228465664
author Silbernagel, Guenther
Kleber, Marcus E.
Grammer, Tanja B.
Winkelmann, Bernhard R.
Boehm, Bernhard O.
März, Winfried
author_facet Silbernagel, Guenther
Kleber, Marcus E.
Grammer, Tanja B.
Winkelmann, Bernhard R.
Boehm, Bernhard O.
März, Winfried
author_sort Silbernagel, Guenther
collection PubMed
description OBJECTIVE: To study the prognosis of people with newly diagnosed type 2 diabetes as per the American Diabetes Association (ADA) 2010 definition but without diabetes as per the ADA 2009 definition. RESEARCH DESIGN AND METHODS: A total of 2,002 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study without a history of diabetes were studied. RESULTS: During the follow-up of a mean duration ± SD of 7.7 ± 2.0 years, 346 people died (202 cardiovascular deaths). Subjects with type 2 diabetes as per the ADA 2009 definition (n = 468) had significantly increased all-cause and cardiovascular mortality compared with people without diabetes as per the ADA 2010 definition (both P ≤ 0.003). Subjects with type 2 diabetes as per the ADA 2010 definition but without diabetes as per the ADA 2009 definition (n = 150) were at significantly increased risk to die of cardiovascular diseases (P = 0.029). CONCLUSIONS: Use of the ADA 2010 diabetes definition may be instrumental in improving cardiovascular risk stratification in people undergoing coronary angiography.
format Online
Article
Text
id pubmed-3198301
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31983012012-11-01 Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk Silbernagel, Guenther Kleber, Marcus E. Grammer, Tanja B. Winkelmann, Bernhard R. Boehm, Bernhard O. März, Winfried Diabetes Care Original Research OBJECTIVE: To study the prognosis of people with newly diagnosed type 2 diabetes as per the American Diabetes Association (ADA) 2010 definition but without diabetes as per the ADA 2009 definition. RESEARCH DESIGN AND METHODS: A total of 2,002 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study without a history of diabetes were studied. RESULTS: During the follow-up of a mean duration ± SD of 7.7 ± 2.0 years, 346 people died (202 cardiovascular deaths). Subjects with type 2 diabetes as per the ADA 2009 definition (n = 468) had significantly increased all-cause and cardiovascular mortality compared with people without diabetes as per the ADA 2010 definition (both P ≤ 0.003). Subjects with type 2 diabetes as per the ADA 2010 definition but without diabetes as per the ADA 2009 definition (n = 150) were at significantly increased risk to die of cardiovascular diseases (P = 0.029). CONCLUSIONS: Use of the ADA 2010 diabetes definition may be instrumental in improving cardiovascular risk stratification in people undergoing coronary angiography. American Diabetes Association 2011-11 2011-10-15 /pmc/articles/PMC3198301/ /pubmed/21911772 http://dx.doi.org/10.2337/dc11-1046 Text en © 2011 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details.
spellingShingle Original Research
Silbernagel, Guenther
Kleber, Marcus E.
Grammer, Tanja B.
Winkelmann, Bernhard R.
Boehm, Bernhard O.
März, Winfried
Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
title Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
title_full Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
title_fullStr Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
title_full_unstemmed Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
title_short Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
title_sort additional use of glycated hemoglobin for diagnosis of type 2 diabetes in people undergoing coronary angiography reveals a subgroup at increased cardiovascular risk
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198301/
https://www.ncbi.nlm.nih.gov/pubmed/21911772
http://dx.doi.org/10.2337/dc11-1046
work_keys_str_mv AT silbernagelguenther additionaluseofglycatedhemoglobinfordiagnosisoftype2diabetesinpeopleundergoingcoronaryangiographyrevealsasubgroupatincreasedcardiovascularrisk
AT klebermarcuse additionaluseofglycatedhemoglobinfordiagnosisoftype2diabetesinpeopleundergoingcoronaryangiographyrevealsasubgroupatincreasedcardiovascularrisk
AT grammertanjab additionaluseofglycatedhemoglobinfordiagnosisoftype2diabetesinpeopleundergoingcoronaryangiographyrevealsasubgroupatincreasedcardiovascularrisk
AT winkelmannbernhardr additionaluseofglycatedhemoglobinfordiagnosisoftype2diabetesinpeopleundergoingcoronaryangiographyrevealsasubgroupatincreasedcardiovascularrisk
AT boehmbernhardo additionaluseofglycatedhemoglobinfordiagnosisoftype2diabetesinpeopleundergoingcoronaryangiographyrevealsasubgroupatincreasedcardiovascularrisk
AT marzwinfried additionaluseofglycatedhemoglobinfordiagnosisoftype2diabetesinpeopleundergoingcoronaryangiographyrevealsasubgroupatincreasedcardiovascularrisk